Skip to main content
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
User login
Username
Password
Reset your password
Specialty
Lead
score
Rheumatology
1
1
Pharmacist
0
0.5
Internal Medicine
0
0.8
Dermatology
0
0.6
Family Medicine/Primary Care
0
0.7
Pediatrics
0
0.9
Concept
Lead
score
Biologic Therapy
1
1
Biosimilars
0
0.99
Psoriatic Arthritis
0
0.2
Child
0
0.19
Crohn Disease
0
0.16
Psoriasis
0
0.16
Ulcerative Colitis
0
0.13
Arthritis
0
0.1
Biomedical Technology
0
0.1
Colitis
0
0.1
Interleukin
0
0.1
Intravenous
0
0.1
Phototherapy
0
0.1
Plaque Psoriasis
0
0.1
Healthcare and Medical Technology
0
0.09
Inflammatory Bowel Disease
0
0.09
Edit Tags